Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time

ClinicalTrials.gov ID: NCT01223365

Public ClinicalTrials.gov record NCT01223365. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 8:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Month, Open-Label Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) at 15 to 90 mg Every 12 Hours in Patients Who Require Opioid Treatment for an Extended Period of Time

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the safety of hydrocodone extended-release tablets when used over a 12-month period in patients with chronic pain, as assessed by adverse events, clinical laboratory results, vital signs measurements, electrocardiogram results, physical examination findings, pure tone audiometry, and concomitant medication usage.

Study identification

NCT ID
NCT01223365
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
330 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2010 (Type not available)
Primary completion
Sep 2012 (Actual)
Completion
Sep 2012 (Actual)
Last update posted
Jun 5, 2017

2010 – 2012

United States locations

U.S. sites
54
U.S. states
25
U.S. cities
49
Facility City State ZIP Site status
Horizon Research Group, LLC Mobile Alabama — —
Physician Alliance Research Center Anaheim California — —
Adam D. Karns, MD Beverly Hills California — —
Associated Pharmaceutical Research Center, Inc. Buena Park California — —
Providence Clinical Research Burbank California — —
Research Center of Fresno, Inc. Fresno California — —
Pacific Coast Pain Management Center Laguna Hills California — —
South Orange County Surgical Medical Group Laguna Hills California — —
Accelovance, Inc. San Diego California — —
Bayview Research Group, LLC Valley Village California — —
Clinical Research of West Florida, Inc. Clearwater Florida — —
Avail Clinical Research, LLC DeLand Florida — —
Compass Research, LLC Orlando Florida — —
Sarasota Pain Medicine Research LLC Sarasota Florida — —
Gold Coast Research LLC Weston Florida — —
Drug Studies America Marietta Georgia — —
Georgia Institute for Clinical Research, LLC Marietta Georgia — —
Taylor Research, LLC Marietta Georgia — —
Better Health Clinical Research, Inc. Newnan Georgia — —
Millennium Pain Center Bloomington Illinois — —
Rehabilitation Associates of Indiana Indianapolis Indiana — —
International Clinical Research, Inc. Overland Park Kansas — —
Community Research Crestview Hills Kentucky — —
Willis Knighton River Cities Clinical Research Center Shreveport Louisiana — —
MidAtlantic Pain Medicine Center Pikesville Maryland — —
Beacon Clinical Research, LLC Brockton Massachusetts — —
HealthCare Research Florissant Missouri — —
Sundance Clinical Research, LLC St Louis Missouri — —
Meridian Clinical Research Omaha Nebraska — —
Clinical Research Center of Nevada Las Vegas Nevada — —
Advanced Pain Consultants Voorhees Township New Jersey — —
Upstate Clinical Research Associates Williamsville New York — —
Wake Research Associates Raleigh North Carolina — —
Sterling Research Group, Ltd. Cincinnati Ohio — —
Columbus Clinical Research Columbus Ohio — —
SP Research Oklahoma City Oklahoma — —
Pain Research of Oregon Eugene Oregon — —
Summit Research Network Inc. Portland Oregon — —
Brandywine Clinical Research Downingtown Pennsylvania — —
AMH Feasterville Family Health Care Center Feasterville-Trevose Pennsylvania — —
Tipton Medical and Diagnostic Center Tipton Pennsylvania — —
Clinical Research Center of Reading, LLP West Reading Pennsylvania — —
Omega Medical Research Warwick Rhode Island — —
Greenville Pharmaceutical Research Greenville South Carolina — —
Trident Institute of Medical Research, LLC North Charleston South Carolina — —
S. Carolina Pharmaceutical Research Spartanburg South Carolina — —
KRK Medical Research Dallas Texas — —
Radiant Research Dallas Texas — —
Renaissance Clinical Research & Hypertension of Texas, PLLC Dallas Texas — —
Medstar Clinical Research Houston Texas — —
Benchmark Research San Angelo Texas — —
DCT-Sugarland, LLC dba Discovery Clinical Trials Sugar Land Texas — —
Hillcrest Family Health Centers Waco Texas — —
Aspen Clinical Research, LLC Orem Utah — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01223365, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2017 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01223365 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →